Abingdon Health Plc (AIM:ABDX)

Market Cap	26.00M
Revenue (ttm)	8.43M
Net Income (ttm)	-3.42M
Shares Out	433.39M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	50,909
Average Volume	113,128
Open	6.50
Previous Close	6.00
Day's Range	5.86 - 6.50
52-Week Range	5.10 - 9.00
Beta	0.18
RSI	27.05
Earnings Date	Mar 24, 2026

About Abingdon Health

Abingdon Health Plc operates as contract research, and contract development and manufacturing organization that develops, manufactures, and distributes diagnostic devices in the United Kingdom, the United States, Canada, Europe, and internationally. The company provides a range of professional-use tests and self-tests to various industries, including healthcare, COVID-19, plant health, and for nucleic acid detection. Abingdon Health Plc was incorporated in 2008 and is headquartered in York, the United Kingdom.

• Industry: Medical - Diagnostics & Research
• Sector: Healthcare
• Founded: 2008
• Employees: 124
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: ABDX

Financial Performance

In 2025, Abingdon Health's revenue was 8.43 million, an increase of 37.39% compared to the previous year's 6.14 million. Losses were -3.42 million, 168.7% more than in 2024.